Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib for cognitive impairment associated with Parkinson's disease
2010-024424-26Phase 2Withdrawn
- Sponsor
- AB Science
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) and Parkinson's disease cognitive impairment (PD-CI) comparing Masitinib with Placebo (2 arms). Planned start Apr 2015; status: withdrawn.
02
Drugs
masitinib
03
Conditions
Parkinson's disease (PD)Parkinson's disease cognitive impairment (PD-CI)
Beyond the preview
Go deeper on 2010-024424-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024424-26.